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ABSTRACT 
The strength of any herbal formulation depends on the delivery of phytoactives to an effective level. This limitation can be overcome 
by development of novel drug delivery systems, which ensure optimized drug delivery, enhanced bioavailability and better stability 
of phyto constituents for better therapeutic effects. Several novel herbal delivery systems have been successfully developed in recent 
years like liposomes, phytosomes, solid-lipid nanoparticles, ethosomes, microemulsions and various other vesicular systems. 
Transfersomes are vesicular drug delivery system having almost same structure like liposomes, but with better skin penetration 
properties to deliver the drugs at deeper skin tissues. Transfersomes are better drug delivery agents due to their ultradeformable 
structure.  
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INTRODUCTION 
From time immemorial it has been the endeavor of the 
physician and the apothecary to provide patients with the 
best possible forms of medicines so that recovery from 
disease is faster and complete. The drugs are delivered 
in a suitable formulation keeping in view the safety, 
efficacy and acceptability among other factors, and the 
formulation is usually known as dosage form or drug 
delivery system. With the progress in all spheres of 
science and technology, the dosage forms have evolved 
from simple mixtures and pills to highly sophisticated 
technology intensive drug delivery systems, which are 
known as Novel Drug Delivery Systems (NDDS) 
1
. 
Much research is being carried out on single herbs, poly-
herbal formulations or herbo-mineral compounds, 
pharmaceutical products, combined treatments and 
disease specific therapies. However, the path remains 
uncertain in terms of standardization of products along 
with safety and efficacy for universal acceptance 
2
. 
Herbal drugs are becoming more popular in the modern 
world for their application to cure variety of diseases 
with less toxic effects 
3
.  
The majority of biological active constituents in plants 
are water soluble like flavonoids, glycosides, tannins etc. 
These phytoconstituents are weakly absorbed, either 
owing to their giant molecular mass that can not be 
absorbed by inert transmission or owing to their reduced 
macromolecular solubility, a factor that severely restricts 
their capability to pass through the lipid rich natural 
membrane, following reduced bioavailability. In novel 
drug delivery technology, control of the distribution of 
drug is achieved by incorporating the drug in carrier 
system or by changing the drug behavior at the 
molecular level. 
Some limitation of herbal extracts / plant actives are, 
instability at high pH, liver metabolism which has lead 
to drug level below therapeutic concentration in the 
blood, resulting in less or no therapeutic effects. 
Other problems which are associated with herbal 
formulation are dose adjustment, maintenance of drug 
release pattern, which reduced efficacy of such system. 
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Advantage of Herbal Novel Drug Delivery System 
Delivery of phytoactives through novel drug delivery 
systems has various advantages over conventional 
dosage forms.  
 Incorporation of novel drug delivery technology to 
herbal of phytoactives minimizes the drug 
degradation or pre-systemic metabolism and other 
side effects by accumulation of drugs to the non-
targeted areas and improves the ease of 
administration 
 Novel drug delivery system is advantageous in 
delivering the herbal drug at predetermined rate and 
delivery of drug at the site of action, which 
minimizes the toxic effects with increased 
bioavailability of drugs. 
 Incorporation of herbal drugs in the delivery system 
also aids to increase in solubility, enhanced 
stability, protection from toxicity, enhanced 
pharmacological activity, improved tissue 
macrophage distribution, sustained delivery and 
protection from physical and chemical degradation. 
 Throughout the extraction method, the drug 
molecules within the herbal medication are exposed 
to oxidation, reduction or many other chemical 
reactive functional groups which cause degradation 
in phytoactive molecules. A nanocoating of those 
drug molecules protects the active chemicals from 
degradations and thus enhance the stability and 
efficacy. 
 It may help in increasing the efficacy and reducing 
the side effects of various herbal compounds and 
herbs. 
 Some drugs have an optimum concentration range 
within which maximum benefit is derived, and 
concentrations above or below this range can be 
toxic or produce no therapeutic benefit, herbal novel 
drug delivery systems eliminates this limitation by 
delivering the correct amount of drug at 
predetermined controlled manner.  
Types of herbal Novel Drug Delivery Systems 
There are various novel drug delivery systems for herbal 
molecules are based on: 
(a) Vascular delivery systems: 
Transfersomes, Ethosomes, Liposomes, 
Phytosomes 
(b) Nano drug delivery systems: 
Micropallets, Microspheres, Nanoparticles 
(c) Biphasic drug delivery systems: 
Micro and Nano-emulsions
 
Table 1: Various Novel Drug Delivery Systems for Phytoactives. 
Delivery System Description Ref 
Invasome Invasomes are the liposomal vesicles, which act as potential carriers with increased skin 
penetration. Invasomes have higher penetration rate through the skin as compared to 
liposomes and ethosomes.  
4 
Ethosomes Ethosomes are noninvasive delivery carriers that enable drugs to reach the deep skin 
layers and/or the systemic circulation. These are soft, malleable vesicles tailored for 
enhanced delivery of active agents. 
5 
Pharmacosomes Pharmacosomes are colloidal dispersions of drugs covalently bound to lipids, and may 
exist as ultrafine vesicular, micellar, or hexagonal aggregates, depending on the chemical 
structure of drug-lipid complex. 
6 
Vesosomes A Vesosome is a more or less heterogeneous, aggregated, a large lipid bi-layer enclosing 
multiple, smaller liposomes that offers a second barrier of protection for interior 
components and can also serve as the anchor for active targeting components. 
7 
Sphingosomes Sphingosomes is bilayer vesicles in which an aqueous volume is entirely enclosed by 
membrane lipid bilayer mainly composed of natural or synthetic sphingolipid. 
Sphingosomes showed higher stability, less in-vivo circulation time. Used to deliver 
chemotherapeutic agent and biological macromolecule. 
8 
Niosomes Niosomes are non-ionic surfactant based vesicles that have a similar structure to that of 
phospholipid vesicles like liposomes. They have ability to increase the stability of 
entrapped drugs, improved bioavailability of poorly absorbed ingredients and enhanced 
skin penetration. 
9 
Nanoparticles Solid lipid nanoparticles are composed of lipid matrix, which becomes solid at room 
temperature and also at the body temperature. The main features of solid lipid 
nanoparticles (SLNs) with regard to parenteral application are the excellent physical 
stability, protection of incorporated labile drugs from degradation. 
10 
Nano-emulsions Micro-emulsion is also called nano-emulsion, and the sub–micro-emulsion is also called 
lipid emulsion. Emulsion drug delivery system is targeted or distributed well due to 
affinity to lymph Micro-emulsions are solutions containing nanometre-sized droplets of 
an immiscible liquid dispersed in an aqueous buffer. 
11 
 
 
Chauhan et al                                                                                                  Journal of Drug Delivery & Therapeutics. 2018; 8(3): 162-168               
ISSN: 2250-1177                                                                             [164]                                                                             CODEN (USA): JDDTAO 
Table 2: Various Vesicular Systems used for herbal drug delivery 
Vesicular System Advantages Limitation 
Liposomes Biocompatible, Biodegradable Stability issue, less penetration property 
Niosomes Improved stability due to use of non-ionic surfactants Skin penetration is not much effective 
Transfersomes Ultradeformable with high stability, high penetration 
property, biodegradable, bio-compatible, incorporate 
low and high molecular weight drugs, penetrate 
deeper skin regions. 
Difficulty in loading hydrophobic drugs 
Phytosomes Higher Bioavailability, enhanced capacity to cross the 
lipid rich biomembranes, better pharmacokinetic and 
therapeutic profile 
leaching of the phytoconstituents 
Ethosomes Increased stability, increased skin permeability and 
inexpensive to formulate 
Loss of product during transfer form 
organic to water media 
 
TRANSFERSOMES 
The name means “carrying bodies’. Transfersomes word 
is derived from the latin word ‘transferee’ which means 
‘to carry across’ and the greek word “soma’ which is 
used for a body. Transfersomes are a type of liposomes 
12
. 
The basic structure of transfersomes is like classic 
liposomes, still it has some differences from liposomes 
by soft nature, ultra-deformable properties, and better 
adjustable nature of system membrane. 
An important property of transfersomes is its ability to 
bind with skin moisture and retain water. Transfersomes 
contains high amount of hydrophilic molecules to avoid 
dehydration. 
The first generation of Transfersomes includes vesicles, 
composed of phospholipids with edge activators. The 
second generation of transfersomes is composed by a 
combination of a bilayer component (e.g. 
phosphatidylcholine) and more than one amphipathic 
membrane destabilizing component. The third 
generation of transfersomes is constituted by 
amphipathic non-phospholipidic bilayers, but unlike the 
first and second generation, the surfactant is replaced by 
water soluble modulator compounds (e.g. organic ions) 
that have the same efficasy 
13
. 
When the transfersomes applied to the skin they move 
deeper towards the water containing strata to acquire 
their hydration. Skin barrier penetration of 
transfersomes is due to reversible bilayer 
ultradeformation, but without losing its integrity 
14
. 
It was claimed that the presence of water gradient exert 
a force in the order of 10”N per vesicle of a radius of 
approximately 60nm. As a result of this force the 
deformable vesicles can be squeezed through lipid 
bilayer. A low interracial tension makes them more 
deformable 
15
. 
Transport driving force magnitude plays an important 
role on the penetration, as 
Flow = area X force X permeability 
The mechanism of transfersomes penetration can be 
explain in steps as initial interaction between 
hydrophilic lipid residue and proximal water, from there 
the polar lipid attracts water molecules, which leads 
induced hydration, the vesicle moves toward the site of 
more water concentration. A trans-epidermal osmotic 
gradient develops, leads to penetration of transfersomes 
across skin 
16
. 
Another possible explanation for the fact that 
transfersomes are able to deliver molecules under non-
occluded conditions could be that, as a result of water 
evaporation from the applied sodium-cholate 
phospholipid aggregate system, concentrated micellar 
system of cholate or collate-phospholipid or both 
generated. The micelles may further delipidize the 
stratum corneum creating small pores through which 
drug penetrates. 
Methods of Transfersomes Preparation  
Various chemicals are used in formulation of 
transfersomes, having various roles i.e. phospholipids, 
surfactants, dyes, alcohol, buffering agents etc. 
 
Table 3: Various ingredients and their role for synthesis of Transfersomes 
Ingredients Chemical Role 
Phospholipids Phosphatidyl choline, soya Phosphatidyl choline, dipalmitoyl 
phosphatidyl choline 
Formation of vesicles 
Surface active agents 
(edge activators) 
Sodium Cholate, Sodium deoxycholate, tween 80, span 80 Flexibility improvement 
Primary alchohol Ethanol, Methanol Solvents 
Buffering agents pH 6.4, phosphate Saline Hydration medium 
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Thin film hydration method 
In this method, phospholipids and surfactants are 
dissolved in suitable organic medium, such as 
chloroform-methanol and prepared a thin film, using 
rotary evaporator. The organic solvent evaporated at 
above the lipid transition temperature at 50
0
C. 
Saline phosphate buffer of pH 6.4 is added to hydrate 
stack of film and subsequently kept for rotation at 
60rpm for 1hr. kept at room temperature for 2 hrs, till 
the swelling of vesicle is completed. Afterwards to 
achieve desired size, the dispersion is sonicated 
17
. 
Modified Hand Shaking Lipid Film Hydeation 
Method 
Phytoconstituent, phosphatidyl choline (lecithin) and 
other additives, such as edge activators (sodium cholate) 
are dissolved in chloroform-ethanol mixture (1:1). The 
mixture of organic solvent is removed by evaporation by 
using rotary evaporator or by hand shaking at 
approximate 43
0
C. 
A stack of thin film of lipid is formed over the inner 
wall of flask. The obtained stack on inner wall is kept 
overnight under vacuumed for complete removal of 
traces of solvents. The phosphate buffer (pH 4) is added 
to rehydrate the film with hand shaking foe 15 min. at 
mentioned temperature. The vesicle of desired size can 
be obtained by sonication 
17
. 
Optimization factors of transfersomes formulation 
The numbers of process variables are responsible to 
obtain the optimized formulation of transfersomes. 
There are various factors that are responsible for the 
same are: 
1. pH 
The pH evaluated by potentiometry affects the molecule 
ionization and consequently its interaction and 
entrapment efficiency. The pH level should be suitable 
for achieving a balance between formulation properties 
and biological applications, including the administration 
route 
18, 19
.  
2. Effect of phosphatidyle choline, edge activator 
ratio- 
These should be an optimized ratio of 
phosphatidylecholine and edge activator, because this 
affects greatly the entrapment efficiency. Higher 
concentration of edge activators may decrease 
entrapment efficiency. Upon incorporation of edge 
activators in low concentration, growth in vesicle size 
occurred 
20
, whereas further increase in the content of 
edge activator may have led to pore formation in the 
bilayer and reduced penetration. 
3. Effect of type of edge activator- 
Deformability and entrapment efficiency of 
transfersomes is affected by the type of edge activators, 
which could be interpreted by difference in their 
chemical structure. One way to explain this effect is to 
consider the HLB of edge activators. In one finding, 
tween 80-3 showed higher deformability. This could be 
attributed to the highly flexible and non-bulky 
hydrocarbon chain of tween-80. Sodium deoxycholate 
(SDC-3) and Sodium cholate (SC-3) has lower 
deformability than tween-80-3 due to thin steroid like 
structure, which are bulkier than hydrocarbon chains of 
tween 80. This could be a result of their high 
hydrophobicity, which reduced the formation of 
transient hydrophilic holes, hence, minimizing the 
amphiphillic property of the bilayer responsible for 
membrane fluidity 
21
. 
4. Effect of Total lipid concentration- 
Various research findings indicated that the fraction of 
lipid taking part in encapsulation was reduced upon 
increasing the total lipid concentration. Total lipid 
concentration used for formulation affects entrapment 
efficiency 
22
.  
Edge activators influenced the vesicular morphology, 
entrapment efficiency, zeta potential, drug release, 
deformability, skin permeation, and skin deposition.  
Evaluation Parameters 
Different parameters are used for characterization and 
optimization of transfersomes: 
(A) Entrapment efficiency- the entrapment efficiency 
is the amount of drug entrapped in the formulation. 
This is determined by separating the entrapped drug 
in vesicles by using various techniques i.e. mini-
column centrifugation. After that the vesicles were 
disrupted using 0.1% triton X-100 or 50% n-
propanol. 
The entrapment efficiency is calculated by using this 
formula 
Entrapment efficiency = 
                         
                           
 X 100 
(B) Diameter of Vesicle- Photon correlation 
spectroscopy or dynamic light scattering method is 
used to determine vesicle diameter. Distilled water 
is used for the preparation of sample and filtered 
through a membrane filter (0.2 mm) and filtered 
saline used to dilute up to certain dilution ratio to 
measure the size of vesicles. 
(C) Degree of deformability or permeability 
measurement- this is an important parameter for 
characterization as this greatly affects the 
permeation of formulation. This study is done by 
passing the preparation through a large number of 
pores of known size (micro porous filters of 50-400 
nm) 
23
.  
Particle size and size distribution are noted after each 
pass by dynamic light scattering (DLS) measurements. 
D= J (rv / rp) 
Where  
D= degree of deformability 
J = amount of suspension extruded during 5 min. 
rv = size of vesicle 
rp = pore size of barrier 
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(D) Measurement of turbidity: Nephelometer is used 
to measure turbidity sample in aqueous solution. 
(E) Surface charge and charge density: Zeta sizer is 
used to measure the surface charge and charge 
density on transfersomes.   
(F) Number of vesicles per cubic mm- Unsonicated 
transfersomes formulation, diluted 5 times with 0.9% 
sodium chloride solution. Hemocytometer with 
optical microscope are used for this study.  
The transfersomes in 80 small squares are counted and 
calculated using formula; 
(Total number of transfersomes) mm
3
 =  
                                                          
                               
  
(G) Vesicle Morphology- vesicle diameter can be 
determined using photon correlation spectroscopy 
(PCS) or Dynamic Light Scattering (DLS). 
Samples were prepared in distilled water, filtered 
through a 0.2 mm membrane filter and dilutes with 
filtered saline and then size measurement can be 
done by using PCS or DLS. 
Transfersomes vesicles can be visualized by 
Transmission electron microscopy (TEM) or pby phase 
contrast microscope. Mean size is measured by DLS and 
TEM, structural changes are observed by TEM 
24
. 
APPLICATION OF TRANSFERSOMES 
Transfersomes have a wide variety of applications in the 
targeting of drug and other molecules through the 
transdermal route. 
1. Delivery of Proteins- 
It is very difficult to transport big and large biogenic 
molecules such as body proteins and peptides into body. 
When administered through oral route, such molecule 
shows degradation in gastrointestinal tract 
25
.  
Transfersomes are the best suitable approach for the 
delivery of all kinds of proteins into body. It is observed 
that bioavailability of the molecules delivered by 
transfersomes are similar to the drug administered by 
subcutaneous injections 
26, 27
. 
The protein preparation e.g. bovine serum albumin 
(immunogenic adjuvent) applied repeatedly in the 
preparation of transfersomes through epi-cutaneous 
route, showed strong immunogenic response.  
Transfersomes has been shown to penetrate the skin 
intact, to present the antigen to dendritic cells and elicit 
an antigen specific immune response 
28
. 
Gap junction proteins loaded in transfersomes elicit 
antigen specific antibody titer that was equivalent to 
subcutaneous route 
29
. 
Plasmid DNA encoding Hepatitis-B surface antigen 
(HBs-Ag)- loaded cationic transfersomes are also 
utilized for topical immunization, and showed 
significantly higher HBs-Ag antibody titer and 
cytokinins level 
30
. 
2. Delivery of Anti-cancer drugs 
Transfersomes are used as carrier for delivery of anti-
cancer drugs; they are suitable specially for treating skin 
cancers. Transfersomes loaded with methotraxate was 
tried for treatment of skin cancer. Tamoxifen (TAM)  
anti breast cancer agent is carried through skin most 
efficiently by means of transfersomes and accelerate the 
growth of murine uteri, where it act as an anti-oestrogen, 
even at low dose as 0.1-0.2 mg/kg/day 
31
. 
3. Delivery of Interferon- 
Transfersomes loaded with immunomodulators, 
Interferon-α and interleukines-2 (IL-2) are successfully 
synthesized and observed that both the molecules 
retained their biological activity and could be efficiently 
encapsulated in carrier 
32
. 
4. Insulin Delivery- 
Orally applied polypeptidic or proteinaceous drugs are 
digested in the gastro-intestinal tract, by and large, and 
thus are therapeutically nearly inactive. Transfersomes 
can transport their associated drugs, including the 
epicutaneously applied insulin, into the body 
spontaneously. This happens in spite of the fact that 
insulin is normally prevented from crossing the skin by 
its high molecular weight of 5808 Da. The self-
regulating membrane deformability of transfersomes is 
closely related to the corresponding vesicles self-
reparation capability, the latter being essential for the 
transfersome stability and practical usefulness. Insulin is 
inferred to be transported into the body between the 
intact skin cells with a bio-efficiency of at least 50% of 
the subcutaneous dose action 
33
. 
5. Delivery of various therapeutic agents 
  
Table 2: Various Drugs used with Transfersomal drug delivery system 
Drug Category Therapeutic activity Ref 
Dexamethasone Corticosteroid Drug Anti-edema activity 34 
Diclofenac NSAID agent Formulation optimization  35 
Tacrolimus  Immunosuppressive  Atopic dermatitis 36 
Pentoxifyllin Xanthine Derivative Chronic occlusive arterial disease. 37 
Eprosartan Mesylate Angiotensin receptor blockers 
(ARBs) 
Management of Hypertension 38 
Ciprofloxacin Quinolone Antibiotic Treatment of otitis media 39 
Timolol maleate Nonselective β-adrenergic blocker Management of Hypertension 40  
Ketoconazole Azole antifungal Antimicrobial activity  41 
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Diclofenac diethylamine,  
Curcumin 
NSAID and natural Phenol 
curcuminoid 
Analgesic and Anti-inflammatory 42 
Itraconazole Antifungal triazoles Formulation Optimization 43 
Paromomycin sulfate Antibiotic cutaneous leishmaniasis 44 
risperidone antipsychotics Formulation Optimization 45 
Minoxidil and caffeine Antihypertensive vasodilator Treatment of alopecia 46 
Raloxifene 
Hydrochloride 
Selective eoestrogen receptor 
modulator (SERM)  
Treatment of osteoporosis 47 
sinomenine 
hydrochloride 
Alkaloid Formulation optimization Treatment of 
Rheumatism  
48 
Embelin Benzoquinone derivative Treatment of Cancer 49 
Indinavir sulfate Protease inhibitor used as a 
component of highly active 
antiretroviral therapy to treat 
HIV/AIDS 
Treatment against AIDS with other 
protease inhibitors, nucleoside analogues 
or reverse transcriptase inhibitors 
50 
Stavudine Reverse transcriptase inhibitors Prevention and treatment of HIV/AIDS 51 
 
CONCLUSION 
Transfersomes has several advantages of transdermal 
drug delivery system. Transfersomes can entrap and 
deliver small and large molecules effectively through 
skin. Their ultradeformable property makes them to 
overcome the skin permeation difficulty, as they squeeze 
themselves to cross the skin layer barriers. But for 
optimized formulation the most critical factor is correct 
ratio of edge activators and phospholipids, which 
governs the flexibility, vesicle layers integrity, and 
entrapment efficiency and stability of the formulation. 
Transfersomes has explored for delivery of macro and 
micro molecules, but lots of phytoconstituents are there 
to explore the potential role of this delivery system.
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